Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NETWORK × Rituximab × Clear all

Phase

Phase 2 23 Phase 3 9 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 12 INDUSTRY 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

sintilimab 1 Vincristine 1 Sevoflurane 1 Rituximab 1 Propofol 1 Mitoxantrone 1 Methotrexate 1 Introns 1 Interferon alpha-2 1 Idarubicin 1 Gastrointestinal Microbiome 1 Drug Therapy 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Danazol 1 Cytarabine 1 Clorazepate Dipotassium 1 Carboplatin 1 Anesthesia, Epidural 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

Bioaraba Health Research Institute

Phase 4 Unknown

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡